MYDA Advisors’s Protara Therapeutics TARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-14,027
Closed -$236K 219
2020
Q3
$236K Buy
+14,027
New +$236K 0.12% 85